ProGnosis Biotech at WHX Labs Dubai 2026

ProGnosis Biotech participation at WHX Labs Dubai 2026 focused on practical systems that support efficient daily workflows, with an emphasis on ATP hygiene monitoring for fast sanitation verification. Attending World Health Expo Labs Dubai 2026, that took place at the Dubai World Trade Centre on February 10–13, offered an opportunity to connect with laboratory experts, healthcare leaders, innovators and technology providers.

World Health Expo Labs Dubai 2026 was held under the patronage of the UAE Ministry of Health and dedicated to “25 years of laboratory innovation”. ProGnosis Biotech attended this 2026 Dubai medical laboratory exhibition to promote reliable diagnostics that reduce complexity in routine verification.

ATP bioluminescence testing for hygiene verification was showcased focusing on its easy applicability, speed and portability. The ATP-Flow testing series supports hygiene verification of surfaces and water samples where needed (for example, CIP systems).

The Hygiene Monitoring solutions included:

  1. ATP hygiene monitoring for food and healthcare environments:
    • ATP-Flow Surface, that supports rapid ATP surface testing for sanitation verification purposes.
  2. ATP water testing for CIP systems and rinse water samples:
    • ATP-Flow Total (Water ATP Test), designed for detecting both microbial and non-microbial ATP in water samples.
  3. A highly sensitive ATP test for settings where very low residue levels matter:
    • ATP-Femto FLOW, featuring an LOD 4 times lower than regular ATP tests and results in 10 seconds, designed for critical environments such as ICUs and cleanrooms.
  4. A portable ATP luminometer, the Phos Reader 2 (video) that delivers fast and reliable readings on its touch screen, the PC or the cloud.
  5. Protein residue detection to validate cleaning effectiveness
    • Protein Flow, a colorimetric protein residue test with visual results available in 10 minutes, designed for routine use without specialized equipment.

In addition to hygiene monitoring, ProGnosis Biotech also presented clinical rapid tests (lateral flow) and food safety diagnostic solutions designed for routine use. Forming a culture around quality verification makes checks easier to perform, interpret and repeat, especially in clinical settings where reliable results support operational dependability.

  • Clinical Diagnostics: Clinical tests for home or professional use, focused on respiratory pathogen detection, including SARS-CoV-2, Influenza A/B, RSV, Adenovirus and Strep A.
  • Food Safety Diagnostics: Food and feed safety lines focus on ensuring consumer safety and product quality by detecting harmful contaminants that can cause serious issues in human and animal health.

WHX Labs Dubai 2026 created strong space for direct discussions with laboratory and healthcare teams on how hygiene verification is performed in real conditions, where speed, portability and straightforward interpretation matter. The conversations around ATP monitoring and routine rapid testing reinforced ProGnosis Biotech’s focus on solutions that are easy to implement, dependable in daily use and designed to support consistent quality checks across healthcare, laboratories and food safety operations.

To see our latest products for hygiene monitoring visit our site here.

Share This Post

More To Explore

Want Exclusive Updates?

Sign up today to access the newest innovations tailored to your diagnostic needs